Edgewise Therapeutics, Inc.

EWTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$45.32-3.45%

2026-09-18

Financials

Valuation Metrics

Edgewise Therapeutics, Inc.'s Market Cap is $4.88B. At end of 2025 it was $2.55B. Ranked #1348 of 3,121 in US market (top 43%), #460 of 1,463 on NASDAQ (top 31%), #81 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 30%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$4.88B	US#1,348/3,121 Sec#81/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-197M	US—/3,121 Sec—/266
Total Assets	$480M	US#2,783/3,121 Sec#170/266
Net Assets	$448M	US#2,306/3,121 Sec#121/266
Value
P/B	10.88x	US#2,663/3,121 Sec#201/266
FCF Yield	-3.27%	US—/3,121 Sec—/266
Profitability
ROE	-44.02%	US#2,654/3,121 Sec#145/266
ROA	-41.11%	US#2,951/3,121 Sec#191/266
Financial Health
Debt Ratio	7.05%	US#65/3,121 Sec#31/266
Total Debt	$4M	US#2,936/3,121 Sec#226/266
FCF	$-160M	US#2,734/3,121 Sec#186/266
Cash	$72M	US#2,411/3,121 Sec#201/266
Current Ratio	16.24x	US#153/3,121 Sec#43/266
Performance
1Y Return	191.82%	US#50/3,121 Sec#20/266
1M Return	-2.41%	US#393/3,121 Sec#41/266
From 52W High	-6.58%	US#169/3,121 Sec#15/266
1Y MDD	-21.01%	US#789/3,121 Sec#31/266
Trading
Volume	1,762,799 shares	US#1,041/3,121 Sec#104/266
Trading Value	$81M	US#1,032/3,121 Sec#73/266
Per Share
EPS	$-1.83	US—/3,121 Sec—/266
BPS	$4.16	US#2,344/3,121 Sec#137/266